BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference
BioCardia, Inc. announced that CEO Dr. Peter Altman will present at the H.C. Wainwright 28th Annual Global Investment Conference, highlighting advancements in CardiAMP autologous cell therapy regulatory submissions in Japan and the US, the ongoing CardiAMP HF II pivotal trial, and developments in their Helix delivery and Heart3D imaging platforms. …